• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22153 Records] Selected Records [0 Hits] [Clear]
Year Source Title
1997     Andalusian Health Technology Assessment Area (AETSA) Prevention of catheter-related infections: cost-effectiveness of a new connection device - non-systematic review
2019     Andalusian Health Technology Assessment Area (AETSA) Clinical Utility of Procalcitonin–Guidance for initiation of antimicrobian treatment in patients admitted to the ICU
1997     Andalusian Health Technology Assessment Area (AETSA) Report on New-Ger (N-duopropenide), a new disinfectant -non-systematic review
2013     Andalusian Health Technology Assessment Area (AETSA) [Genetic testing for predicting treatment response in major depressive disorders]
1998     Andalusian Health Technology Assessment Area (AETSA) [An evidence-based guideline on unstable angina management]
2013     Andalusian Health Technology Assessment Area (AETSA) [CardioWest™ TAH-t. Total artificial heart]
2013     Andalusian Health Technology Assessment Area (AETSA) [Recommendations for the proper use of inverted shoulder prosthesis]
1998     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of prostate cancer screening and its application in Andalucia]
2013     Andalusian Health Technology Assessment Area (AETSA) [Treatment with biological drugs in adult patients with moderate to severe plaque psoriasis: relative efficacy, safety and efficiency]
2013     Andalusian Health Technology Assessment Area (AETSA) [Guide for proper use of knee arthroplasty in patients with arthritis. Short version]
2021     Andalusian Health Technology Assessment Area (AETSA) [Laser interstitial thermal therapy for patients with refractory epilepsy: safety and effectiveness. A systematic review]
2013     Andalusian Health Technology Assessment Area (AETSA) [Guide for proper use of knee arthroplasty in patients with arthritis. Fast version]
2013     Andalusian Health Technology Assessment Area (AETSA) [Guide for proper use of knee arthroplasty in patients with arthritis]
2013     Andalusian Health Technology Assessment Area (AETSA) [Guide for the preparation of drug evaluation reports]
2014     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline on intravenous therapy with temporary devices in adults]
2011     Andalusian Health Technology Assessment Area (AETSA) [Eculizumab (Soliris®) Assessment of effectivity and safety of the drug and economic analysis of use in Paroxysmal Nocturnal Haemoglobinuria therapy]
2012     Andalusian Health Technology Assessment Area (AETSA) [Rapid tests for methicillin resistant Staphylococcus aureus. Carrier screening. Executive summary]
2014     Andalusian Health Technology Assessment Area (AETSA) [Guide to clinical practice of care in pregnancy and puerperium]
2007     Andalusian Health Technology Assessment Area (AETSA) Effectivity of erythropoietin in autologous blood transfusion for bleeding surgery
2013     Andalusian Health Technology Assessment Area (AETSA) [Fidaxomicin for the treatment of clostridium difficile infection]
2014     Andalusian Health Technology Assessment Area (AETSA) [Rapid review. Gender dysphoria. Diagnosis, treatment and health outcomes]
2014     Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in transplant patients with chronic hepatitis c]
2014     Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in patients with chronic hepatitis c waiting for liver transplant]
2007     Andalusian Health Technology Assessment Area (AETSA) [3 Tesla Magnetic Resonance Imaging]
2014     Andalusian Health Technology Assessment Area (AETSA) [Summary of evidence for efficacy and safety of sofosbuvir in patients with chronic hepatitis c coinfected with human immunodeficiency virus]
2023     Andalusian Health Technology Assessment Area (AETSA) [Appropiate indication for leadless pacemaker. Systematic review and appropriateness criteria]
2008     Andalusian Health Technology Assessment Area (AETSA) [Magnetic Resonance imaging for breast cancer diagnostics. Systematic review and economic assessment]
2014     Andalusian Health Technology Assessment Area (AETSA) [Selection criteria for direct antiviral agents for patients with chronic hepatitis c in a severe clinical situation in the SSPA]
2009     Andalusian Health Technology Assessment Area (AETSA) [Helical tomotherapy. Current uses and utility]
2014     Andalusian Health Technology Assessment Area (AETSA) [Updating of selection criteria for direct antiviral agents for patients with chronic hepatitis c in a severe clinical situation in the SSPA]
2015     Andalusian Health Technology Assessment Area (AETSA) [Balloon eustachian tuboplasty for the treatment of eustachian tube dysfunction]
2009     Andalusian Health Technology Assessment Area (AETSA) [Endovascular treatment for thoracic aorta lesions]
2015     Andalusian Health Technology Assessment Area (AETSA) [Selection criteria for direct antiviral agents for patients with chronic hepatitis c in the SSPA]
2004     Andalusian Health Technology Assessment Area (AETSA) Systematic review: evaluation methodology of health services based on telemedicine and e-health
2007     Andalusian Health Technology Assessment Area (AETSA) [Radiofrequency ablation of breast tumours]
2014     Andalusian Health Technology Assessment Area (AETSA) [Communication strategies with children and adolescents in the hospital or primary care setting]
2010     Andalusian Health Technology Assessment Area (AETSA) [Utility of 90Y-Ibritumomab Tiuxetan (Zevalin) in the treatment of adult patients with non-Hodgkin lymphoma]
2015     Andalusian Health Technology Assessment Area (AETSA) [Simeprevir in the treatment of chronic hepatitis C. Comparative efficacy and safety assessment]
2010     Andalusian Health Technology Assessment Area (AETSA) [Vaccine for the prevention of Alzheimer's disease]
2016     Andalusian Health Technology Assessment Area (AETSA) [Guide for the preparation of evidence synthesis reports: medicines. Update]
2007     Andalusian Health Technology Assessment Area (AETSA) [AmpliChip CYP450: Cytochrome P450 genotyping in psychiatric patients]
2011     Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of rheumatoid arthritis]
2017     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline on the management of vasomotor and vaginal symptoms associated with menopause and postmenopause]
2000     Andalusian Health Technology Assessment Area (AETSA) [Appropriate use of Factor VIII in the treatment of haemophilia. A Literature review and opinions of an expert panel on the correct use of different preparations of Factor VIII]
2017     Andalusian Health Technology Assessment Area (AETSA) [Guideline for the elaboration of recommendations and appropriate use criteria in health technologies]
2009     Andalusian Health Technology Assessment Area (AETSA) [Organizational alternatives for anesthesia in cataract surgery]
2011     Andalusian Health Technology Assessment Area (AETSA) [Prenatal screening for aneuploidy using free fetal DNA in maternal blood. Systematic review of the literature.]
2017     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guidelines for hemotherapy. Brief report]
2010     Andalusian Health Technology Assessment Area (AETSA) [Tool for the assessment of drugs for the treatment of inborn errors of metabolism. Anderson- Fabry disease]
2011     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of active immunotherapy in HIV-infected adults. Therapeutic vaccines against HIV.]
2017     Andalusian Health Technology Assessment Area (AETSA) [Neonatal hypoacusis screening]
2010     Andalusian Health Technology Assessment Area (AETSA) [Confocal microscopy in ophthalmology: Report summary of emergent technology]
2011     Andalusian Health Technology Assessment Area (AETSA) [Use of QALYs in different clinical situations]
2012     Andalusian Health Technology Assessment Area (AETSA) [Allomap genetic test for cardiac transplant rejection]
2017     Andalusian Health Technology Assessment Area (AETSA) [Faecal microbiota transplant for recurrent clostridium difficile infection. Up-date]
2009     Andalusian Health Technology Assessment Area (AETSA) [Internet, health and citizenship]
2011     Andalusian Health Technology Assessment Area (AETSA) [Impella Recover® 2.5 ventricular assist device]
2012     Andalusian Health Technology Assessment Area (AETSA) [Heterochromatic flicker photometry for the detection of the risk of age-related macular degeneration]
2016     Andalusian Health Technology Assessment Area (AETSA) [Toolkit for the early awareness and alert systems in Spain (RedETS)]
2007     Andalusian Health Technology Assessment Area (AETSA) [Planned home birth. Current situation in developed countries]
2011     Andalusian Health Technology Assessment Area (AETSA) [Application of genetic algorithms and expert systems in medical care. Clinical applications of artificial intelligence]
2012     Andalusian Health Technology Assessment Area (AETSA) [MicroRNAs as a diagnostic tool for lung cancer]
2017     Andalusian Health Technology Assessment Area (AETSA) [Efficacy, effectiveness and safety of physiotherapy in patients with multiple sclerosis. Rapid response]
2010     Andalusian Health Technology Assessment Area (AETSA) [Tool for the assessment of drugs for the treatment of inborn errors of metabolism. Gaucher disease]
2012     Andalusian Health Technology Assessment Area (AETSA) [Invasive telemonitoring in patients with heart failure]
2017     Andalusian Health Technology Assessment Area (AETSA) [Rapid response: Effectiveness and safety of hyperthermia in combination with radiation therapy and/or chemotherapy in the treatment of breast, cervix and rectum cancer]
2010     Andalusian Health Technology Assessment Area (AETSA) [4D Ultrasound]
2012     Andalusian Health Technology Assessment Area (AETSA) [Digital tomosynthesis of the breast]
2018     Andalusian Health Technology Assessment Area (AETSA) [Epigenetic profile for the identification of primary cancer of unknown origin]
2009     Andalusian Health Technology Assessment Area (AETSA) [Report NDP disinfectant (R) Med Concentrate (N-Duopropenide). Update 2008]
2012     Andalusian Health Technology Assessment Area (AETSA) [Magnetic resonance guided focused ultrasound for uterine myomas ablation]
2005     Andalusian Health Technology Assessment Area (AETSA) [Framework for the assessment of genetic testing in the Andalusian public health system]
2012     Andalusian Health Technology Assessment Area (AETSA) [High-dose chemotherapy in the salvage treatment of metastatic germ cell tumours]
2018     Andalusian Health Technology Assessment Area (AETSA) [Point of care test for differential diagnosis of virus versus bacteria in acute respiratory tract infection]
2009     Andalusian Health Technology Assessment Area (AETSA) [Manual to adapt health technology assessment reports to the public (MADETSCI)]
2012     Andalusian Health Technology Assessment Area (AETSA) [Radiosurgery and stereotactic body radiation therapy. Efficacy, safety and efficiency in primary lung cancer and pulmonary oligometastases]
2018     Andalusian Health Technology Assessment Area (AETSA) [Cardiopoietic stem cells for the treatment of heart failure secondary to myocardial ischemia]
2001     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guideline for medical management of otitis media in childhood]
2013     Andalusian Health Technology Assessment Area (AETSA) [Tumor treating fields therapy (TTF) for glioblastoma. A systematic review of the literature]
2018     Andalusian Health Technology Assessment Area (AETSA) [Health technology assessment network in the SSPA. Methodology and work procedures]
2005     Andalusian Health Technology Assessment Area (AETSA) Biological indicators for sterilization of medical devices in primary care
2007     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness of knee arthroscopy]
2018     Andalusian Health Technology Assessment Area (AETSA) [Clinical practice guidelines on severe mental disorder]
2005     Andalusian Health Technology Assessment Area (AETSA) Efficacy and safety of inhaled insulin for the treatment of diabetes mellitus
2007     Andalusian Health Technology Assessment Area (AETSA) [Selective screening for lung cancer with chest CT]
2019     Andalusian Health Technology Assessment Area (AETSA) [Blood test for the early diagnosis of pancreatic cancer. CancerSEEK]
2006     Andalusian Health Technology Assessment Area (AETSA) Multi-slice computerised tomography coronary angiography
2007     Andalusian Health Technology Assessment Area (AETSA) [Transcutaneous biosensors]
2019     Andalusian Health Technology Assessment Area (AETSA) [Post-introduction observational study of predictive/prognostic tests in breast cancer of the Andalusian Public Health System (SSPA)]
2006     Andalusian Health Technology Assessment Area (AETSA) Stabilised hyaluronic acid in the treatment of osteoarthritis
2010     Andalusian Health Technology Assessment Area (AETSA) [Isolated limb perfusion for locally advanced melanoma and soft tissue sarcoma]
2013     Andalusian Health Technology Assessment Area (AETSA) [Biological therapies in the treatment of anaemia associated with chronic kidney disease: a comparison of efficacy and safety of different erythropoiesis-stimulating agents]
2020     Andalusian Health Technology Assessment Area (AETSA) [Tumor field therapy in the treatment of glioblastoma. Update]
2006     Andalusian Health Technology Assessment Area (AETSA) Description of citizen's participation initiatives in the planning and implementation of health systems policies
2010     Andalusian Health Technology Assessment Area (AETSA) [Economic evaluation of monitoring systems of ketones in blood for the diagnosis and prevention of ketoacidosis]
2012     Andalusian Health Technology Assessment Area (AETSA) [Efficacy and safety of the immunoregulatory drugs interferon beta and glatiramer in the treatment of relapsing remitting multiple sclerosis]
2020     Andalusian Health Technology Assessment Area (AETSA) [Care model for women with endometriosis. Systematic review of clinical practice guidelines]
2006     Andalusian Health Technology Assessment Area (AETSA) Non invasive diagnosis of celiac disease
2006     Andalusian Health Technology Assessment Area (AETSA) Identification of circulating tumour cells in metastatic breast cancer with the CellSearch (TM) system
2000     Andalusian Health Technology Assessment Area (AETSA) Appropriate use of factor VIII in the treatment of hemophilia A - consensus conference